Navigation Links
VisionGate to Present at IASLC Meeting Showing How Adjunctive Use of Its 3D Cell Imaging Platform Can Increase Utility of CT Screening for Lung Cancer
Date:7/3/2011

AMSTERDAM and PHOENIX, July 4, 2011 /PRNewswire/ -- VisionGate, Inc., a company developing a revolutionary non-invasive test for the early detection of lung cancer, today announced that it will present data showing how adjunctive use of its LuCED™ test can improve the utility of low dose x-ray computed tomography (CT) screening for the early detection of lung cancer in high risk individuals.  LuCED uses VisionGate's revolutionary automated 3D cell imaging platform, the Cell-CT™, which generates high-resolution 3D biosignatures from intact cells using a sputum sample.  The data will be presented at the International Association for the Study of Lung Cancer's 14th World Conference on Lung Cancer on July 7, 2011 from 9:30am-12:30pm CEST.

The proposed first use of LuCED as an adjunct to CT screening reflects the results of the National Cancer Institute's (NCI) landmark National Lung Screening Trial (NLST) of more than 53,000 current and former heavy smokers, which showed that low-dose helical CT screening reduced lung cancer deaths by 20% compared to standard chest x-rays.  These dramatic results were first presented last November and were expanded this week in the June 29, 2011 online edition of the New England Journal of Medicine.  

The NLST findings are generating widespread interest in the broad use of CT screening as a way to reduce lung cancer deaths in high-risk populations.  However, the utility of the approach is hampered by the high rate of false positive results seen in the study — according to the NCI, more than 96% of the positive results from low-dose CT screening over three rounds of testing turned out to be false positive findings, representing almost a quarter (23.3%) of the overall test results.  These false positive test results require follow-up care that results in unnecessary invasive procedures for many patients and significantly higher costs for the healthcare system a
'/>"/>

SOURCE VisionGate, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CardioFocus HeartLight™ Endoscopic Ablation System Enables Treatment of Atrial Fibrillation: Live Case and Abstract Presented at EHRA EUROPACE 2011
2. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
3. Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011
4. Analysis Shows BYDUREON™ Was Not Associated with Clinically Relevant QT Prolongation in Patients with Type 2 Diabetes: Results Presented at ADA 2011
5. Analysis Finds BYETTA® Associated with Lower Likelihood of Heart Failure Compared with Other Diabetes Therapies: Results Presented at ADA 2011
6. Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Associations 71st Annual Scientific Sessions
7. Prime Therapeutics Vice President of Specialty Pharmacy Solutions Presents at 6th Annual Executive Forum on Pharmacy Benefit Management Strategies
8. PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was
9. MAP Pharmaceuticals to Present Data on LEVADEX® at the 15th Congress of the International Headache Society
10. MacroGenics Announces Presentation of Protege Phase 3 Clinical Data at ADA in San Diego on June 28
11. Asmacure Ltee to Present at the 2011 BIO Business Forum During the Annual BIO International Convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Tianyin Pharmaceutical Co., Inc. (NYSE Amex: ... specializes in patented biopharmaceutical, modernized traditional Chinese medicine ... today updates the timeline for the GMP certification ... The Company is scheduled to submit the ... & Drug Administration,s (CFDA) review in the week ...
(Date:8/28/2014)...  Decision Resources Group finds that the market for colorectal ... by 2023 in the United States , ... Italy , Spain , ... Japan . The biosimilar erosion of Roche/Genentech/Chugai,s Avastin and ... the launch of Eli Lilly,s Cyramza, Taiho Pharmaceutical,s Lonsurf, Alchemia,s ...
(Date:8/28/2014)... Levi & Korsinsky announces that a class ... District Court for the District of Nevada ... Therapeutics Inc. ("Galectin" or the "Company") (NasdaqCM: GALT) securities ... For more information, click here: http://zlk.9nl.com/galectin-therapeutics-galt . ... Period the Company violated federal securities laws by issuing ...
Breaking Medicine Technology:TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2
... China, Dec. 27, 2011 /PRNewswire-Asia/ -- China Botanic ... ("China Botanic" or the "Company"), a developer, manufacturer ... Chinese Medicines ("TCM") in China, today announced that ... the 66th PHARMCHINA fair ("the Fair") recently held ...
... Reportlinker.com announces that a new ... its catalogue: Europe ... 2017- Glucose Monitoring and Insulin Delivery ... Europe Diabetes Care Devices ...
Cached Medicine Technology:China Botanic Exhibits All-Natural Anti-depressant Products at the 66th PHARMCHINA Fair 2China Botanic Exhibits All-Natural Anti-depressant Products at the 66th PHARMCHINA Fair 3Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 2Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 3Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 4Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 5Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 6Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 7Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 8Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 9Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 10Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 11Europe Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery 12
(Date:8/29/2014)... 29, 2014 According to The Madison-St. ... Pfizer Inc., Greenstone LLC and Pfizer R&D Cortex District ... defects as a result of using Zoloft during ... filed in St. Clair County Circuit Court (Case No. ... the defendant companies allegedly concealed the risks of serious ...
(Date:8/29/2014)... 29, 2014 Until now, databases have ... or unstructured data (document stores). SQL products have handled ... basically managed the wide assortment of unstructured data. It ... with Big Data is with a NoSQL Database. Unique ... aspects of all Big Data issues. Scientel ...
(Date:8/28/2014)... Career Step, an online provider of career-focused education ... to help students and career seekers explore the opportunities ... video details what medical coders and billers do, what ... education requirements for entering this field. , “Medical coding ... people are considering a career in healthcare,” said Jerolyn ...
(Date:8/28/2014)... When David Gergen, President of Pro Player ... was asked to publicly support Mr. Brnovich in his ... seat in the State of Arizona, Mr. Gergen could ... Hall of Fame wide receiver Roy Green in addition ... Green, Kennard and Walczak are members of Pro Player ...
(Date:8/28/2014)... emergency department with complaints of nausea, vomiting, anxiety ... business lunches, and at home every evening. Worried ... and had his last Scotch 24 hours before ... in emergency rooms across Canadaa patient suddenly stops ... Withdrawal is a potentially fatal condition that is ...
Breaking Medicine News(10 mins):Health News:The Law Office of Melinda J. Helbock A.P.C. Comments on Zoloft Birth Defect Lawsuit 2Health News:Scientel Announces Support for SQL Queries and Relational Tables Within Its Gensonix® NoSQL DB 2Health News:Scientel Announces Support for SQL Queries and Relational Tables Within Its Gensonix® NoSQL DB 3Health News:Scientel Announces Support for SQL Queries and Relational Tables Within Its Gensonix® NoSQL DB 4Health News:Career Step Releases New Video Designed to Help Students Explore the Medical Coding and Billing Field 2Health News:Pro Player Health Alliance Back in the Political Arena 2Health News:Pro Player Health Alliance Back in the Political Arena 3Health News:Real tremors, or drug-seeking patient? New app can tell 2Health News:Real tremors, or drug-seeking patient? New app can tell 3
... ... you up-to-date on embargoed studies and other news being presented at the ... 23-27 in Seattle. All briefs are embargoed until the date/time they are ... registration, or to arrange interviews with presenters, please contact ASPS Public Relations ...
... /PRNewswire-Asia-FirstCall / -- Winner Medical,Group Inc. (OTC Bulletin Board: WWIN; ... largest exporter by volume in the medical,dressing industry in China, ... 6, 2009. , The Company will ... under the new symbol "WWIN" when market opened on October ...
... 6 People with primary immunodeficiency diseases (PIDD) and ... one another and share their experiences through a new ... Foundation (IDF) announced today. Primary immunodeficiency ... by hereditary or genetic defects in the immune system. ...
... identifies competitive advantage for employers from effective health, ... Oct. 6 To help employers gauge benefits-program ... today the country,s largest single-source benchmarking database across ... The 2008 IBI Benchmarking database compares how employers, ...
... Institutes of Health announced today a second phase of ... for 19 research consortia. The Rare Diseases Clinical Research ... be awarded a total of just over $117 million ... the new funding will explore the natural history, epidemiology, ...
... led some organizations and communities to establish smoking bans ... effectiveness of such bans in protecting people from health ... a matter of continuing debate. Secondhand-Smoke Exposure and ... report from the Institute of Medicine, provides a comprehensive ...
Cached Medicine News:Health News:Plastic Surgery 2009 News Briefs -- Research To Be Presented on Saturday, October 24 2Health News:Plastic Surgery 2009 News Briefs -- Research To Be Presented on Saturday, October 24 3Health News:Plastic Surgery 2009 News Briefs -- Research To Be Presented on Saturday, October 24 4Health News:Plastic Surgery 2009 News Briefs -- Research To Be Presented on Saturday, October 24 5Health News:Winner Medical One for Two Reverse Stock Split Becomes Effective and Begins Trading Under New Symbol: WWIN 2Health News:Immune Deficiency Foundation Among the First Rare Disease Patient Organizations to Launch Major Social Networking Initiatives 2Health News:Immune Deficiency Foundation Among the First Rare Disease Patient Organizations to Launch Major Social Networking Initiatives 3Health News:Integrated Benefits Institute Announces Availability of 2008 IBI Benchmarking Industry Reports 2Health News:Integrated Benefits Institute Announces Availability of 2008 IBI Benchmarking Industry Reports 3Health News:NIH announces expansion of Rare Diseases Clinical Research Network 2Health News:NIH announces expansion of Rare Diseases Clinical Research Network 3Health News:NIH announces expansion of Rare Diseases Clinical Research Network 4Health News:NIH announces expansion of Rare Diseases Clinical Research Network 5Health News:NIH announces expansion of Rare Diseases Clinical Research Network 6Health News:NIH announces expansion of Rare Diseases Clinical Research Network 7Health News:NIH announces expansion of Rare Diseases Clinical Research Network 8
... Your patient will be more comfortable, ... tracheostomy tube stabilization more secure and to ... tying and untying of twill ties, consider ... adult and neonate/infant sizes, the narrow fastener ...
... for ease of use and patient comfort, ... edges for comfort and is available in ... a perfect fit. For hard to fit ... collar to your specifications. Don't just take ...
... in place. Soft strap features an adjustable ... compliant foam laminate with elastic adjustment increases ... while still providing a snug fit. Soft ... prevent sliding and patient irritation, and also ...
... and alternate care facilities with a ... which offer the finest in nursing ... the guidance of experienced nursing personnel, ... what is required for efficient and ...
Medicine Products: